Gilead Sciences (GILD) and Terray Therapeutics have entered into a strategic collaboration to discover and develop small ...
Gilead Sciences Inc. closed $6.85 short of its 52-week high ($98.90), which the company achieved on November 11th.
Shares of Assembly Biosciences (NASDAQ:ASMB) traded higher on Thursday after Gilead Sciences (NASDAQ:GILD) agreed to increase ...
Investors are bullish on Gilead as the stock surges on successful launches and strong financial health, offering potential ...
About 40 customers of the Mt. Gilead-Improve Water Association in Columbia were put on a boil-water notice Sunday ...
Gilead is going to start testing a drug it believes could prevent HIV infection with just a single shot every year.
Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the ...
Science magazine has chosen twice-yearly lenacapavir PrEP as its 2024 Breakthrough of the Year, recognizing it as a ...
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy $120 million series B ...
Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent ...
FOSTER CITY, Calif., December 20, 2024--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference: J.P. Morgan ...